In 2027, it is anticipated that the global market for molecular diagnostics point of care would grow to $4.84 billion.
In 2027, it is anticipated that the global market for molecular diagnostics point of care would grow to $4.84 billion. Continued research and development to miniaturise tests with molecular diagnostics that enable more patient testing with higher precision and quicker turnaround times are the primary reasons that are anticipated to strengthen the high growth potential for POC MDx products.
Over the predicted period, rising need in non-laboratory settings such pharmacy clinics, medical offices, and home care tests—which are, by definition, portable and safe—would probably result in lower market demand. CLIA tests are anticipated to see a rise in demand. Governments of developing nations and a handful of other sizable international organisations actively promote and finance ongoing research and development.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/11
Additionally, over the past ten years, a wide range of point-of-care testing technologies have developed quickly with the aim of expanding their potential market to a wider range of medical faculties. These technologies were initially concentrated on the screening, monitoring, and diagnosis of infectious diseases in low-income developing countries. As a result, haematological testing, oncological testing, and cardiological monitoring are now offered or being developed.
Recent advancements in genetic sequencing and microfluidics technology have paved the way for the development of low-cost, extremely accurate, and quick test platforms that can be employed as POC systems. This is a significant aspect that adds significantly to the PoC molecular diagnostics market’s well-funded, high growth potential.
Some Key Highlights from the Report
- Due to the existence of numerous large corporations with a diverse product offering, POC MDx research is utilised in the majority of consumer incomes for infectious diseases.
- The increased incidence of infectious diseases in both developed and emerging nations is another reason for this section’s predominance.
- PCR-based POC studies are the industry segment that generates the most sales. There are several reasons for the category to increase thanks to the widespread usage of PCR-based technology for PCR products for molecular diagnosis and marketing.
- The most developed medical system in the world, as well as public and private efforts in R&D to advance MDx POC testing, made North America the greatest region in terms of revenue generation.
- Abbott Laboratories, Bayer Healthcare, Roche Diagnostics, Bio-Rad Laboratories, Danaher Corporation, BioMerieux, Dako, Abaxis Inc., OraSure Technologies Inc., and Nipro Diagnostics are a few of the major competitors in the market.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/molecular-diagnostics-point-of-care-market
For the purpose of this report, Emergen Research has segmented into the global Molecular Diagnostics Point of Care Market on the basis of Test Location, Technology, Application, End-Use, and region:
Test Location Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)
-
- Over-the-Counter (OTC)
- PoC
Technology Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)
-
- PCR-based
- Genetic Sequencing-based
- Hybridization-based
- Microarray-based
Application Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)
-
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Others
End-Use Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)
-
- Decentralized Labs
- Hospitals
- Homecare
- Assisted Living Healthcare Facilities
- Others
Regional Outlook (Revenue: USD Billion; Volume: Million Tons; 2017-2027)
-
- North America
- S.
- Canada
- Europe
- UK
- Germany
- France
- BENELUX
- Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- MEA
- Saudi Arabia
- UAE
- Rest of MEA
- North America
Make an Inquiry Before Buying@ https://www.emergenresearch.com/purchase-enquiry/11
Explore More Reports Emergen Research:
Organic Electronics Market: https://www.emergenresearch.com/industry-report/organic-electronics-market
Industrial Sensors Market: https://www.emergenresearch.com/industry-report/industrial-sensors-market
Power Monitoring Market: https://www.emergenresearch.com/industry-report/power-monitoring-market
Temperature Monitoring Systems Market: https://www.emergenresearch.com/industry-report/temperature-monitoring-systems-market
Environmental Testing Equipment Market: https://www.emergenresearch.com/industry-report/environmental-testing-equipment-market
Air Quality Monitoring System (AQMS) Market: https://www.emergenresearch.com/industry-report/air-quality-monitoring-system-market
Micro Displays Market: https://www.emergenresearch.com/industry-report/micro-displays-market
Photolithography Equipment Market: https://www.emergenresearch.com/industry-report/photolithography-equipment-market
Lab-on-a-chip (LOC) Market: https://www.emergenresearch.com/industry-report/lab-on-a-chip-market
Particle Size Analysis Market: https://www.emergenresearch.com/industry-report/particle-size-analysis-market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/press-release/global-molecular-diagnostics-point-of-care-market